Loris De Cecco Selected Research

Oxaliplatin (Eloxatin)

1/2023

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loris De Cecco Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 09/2004
25	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2005
13	Ovarian Neoplasms (Ovarian Cancer) 04/2023 - 10/2004
12	Squamous Cell Carcinoma of Head and Neck 01/2024 - 04/2015
5	Disease Progression 01/2024 - 12/2017
5	Ovarian Epithelial Carcinoma 01/2022 - 07/2015
5	Carcinoma (Carcinomatosis) 01/2020 - 03/2010
5	Carcinogenesis 12/2019 - 10/2004
4	Melanoma (Melanoma, Malignant) 01/2024 - 06/2004
4	Glioma (Gliomas) 06/2023 - 06/2014
4	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 09/2018
3	Adenocarcinoma of Lung 10/2022 - 06/2009
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 01/2016
2	Lung Neoplasms (Lung Cancer) 10/2022 - 09/2018
2	Inflammation (Inflammations) 10/2022 - 11/2017
2	Infections 03/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 11/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2012
1	Medulloblastoma 07/2023
1	Osteosarcoma (Osteogenic Sarcoma) 06/2023
1	Neutropenia 06/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Oropharyngeal Neoplasms 12/2022
1	Oncogene Addiction 11/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Circulating Neoplastic Cells 01/2022

Drug/Important Bio-Agent (IBA)

26	MicroRNAs (MicroRNA)IBA 09/2022 - 03/2010
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2009
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
9	Estrogen ReceptorsIBA 11/2022 - 06/2005
7	PlatinumIBA 01/2024 - 01/2013
6	Cetuximab (Erbitux)FDA Link 10/2022 - 01/2016
5	Trastuzumab (Herceptin)FDA Link 11/2022 - 09/2015
5	Messenger RNA (mRNA)IBA 11/2022 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2004
4	Phenobarbital (Luminal)FDA Link 01/2023 - 07/2015
4	Complementary DNA (cDNA)IBA 06/2008 - 06/2004
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
3	VemurafenibIBA 01/2024 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2023 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 07/2015
3	Urethane (Ethyl Carbamate)IBA 11/2017 - 04/2014
3	Cisplatin (Platino)FDA LinkGeneric 07/2015 - 10/2011
3	CPG-oligonucleotideIBA 01/2013 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 10/2011
2	PlasticsIBA 01/2024 - 11/2018
2	NivolumabIBA 01/2024 - 01/2021
2	AntibodiesIBA 01/2024 - 12/2022
2	trametinibIBA 01/2024 - 11/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2019
2	Choline (Choline Chloride)IBA 12/2023 - 01/2021
2	dipinacoline glutamateIBA 06/2023 - 06/2014
2	Complement System Proteins (Complement)IBA 02/2023 - 12/2021
2	Estrogen Receptor alphaIBA 01/2023 - 06/2008
2	olaparibIBA 01/2023 - 07/2015
2	CytokinesIBA 12/2022 - 01/2016
2	Estrogens (Estrogen)FDA Link 11/2022 - 06/2008
2	Long Noncoding RNAIBA 01/2020 - 01/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 07/2018 - 06/2014
2	nimotuzumabIBA 07/2018 - 06/2014
2	Type 4 Fibroblast Growth Factor ReceptorIBA 06/2009 - 10/2004
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2008 - 06/2005
1	Interleukin-8 (Interleukin 8)IBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	IpilimumabIBA 01/2024
1	Tramadol (K315)FDA LinkGeneric 01/2024
1	Protons (Proton)IBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 06/2023
1	Bevacizumab (Avastin)FDA Link 04/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023
1	Ampicillin (Omnipen)FDA LinkGeneric 02/2023
1	Adenosine Monophosphate (AMP)IBA 02/2023
1	16S Ribosomal RNAIBA 02/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2023
1	LipidsIBA 12/2022
1	Conditioned Culture MediaIBA 12/2022
1	dabrafenibIBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2022
1	Drug CombinationsIBA 11/2022
1	CarcinogensIBA 10/2022
1	AerosolsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Circulating MicroRNAIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022

Therapy/Procedure

27	Therapeutics 01/2024 - 10/2008
14	Drug Therapy (Chemotherapy) 07/2023 - 10/2011
5	Immunotherapy 04/2024 - 01/2017
4	Neoadjuvant Therapy 01/2022 - 01/2021
3	Re-Irradiation 07/2023 - 06/2014
2	Radiotherapy 12/2022 - 06/2014
2	Aftercare (After-Treatment) 01/2022 - 01/2021
1	Tertiary Prevention 01/2023
1	Salvage Therapy 01/2022